Infective endocarditis in French Polynesia: Epidemiology, treatments and outcomes

Arch Cardiovasc Dis. 2020 Apr;113(4):252-262. doi: 10.1016/j.acvd.2019.12.007. Epub 2020 Feb 15.

Abstract

Background: French Polynesia is a French overseas collectivity in the South Pacific Ocean, where data on infective endocarditis (IE) are lacking.

Aims: To investigate the epidemiology and outcomes of IE in French Polynesia.

Methods: All hospital records from consecutive patients hospitalized in Taaone Hospital, Tahiti, from 2015 to 2018, with an International Classification of Diseases, 10th revision, separation diagnosis of IE (I330), were reviewed retrospectively.

Results: From 190 hospital charts reviewed, 105 patients with a final diagnosis of IE, confirmed according to the modified Duke criteria, were included. The median duration of follow-up was 71 days (interquartile range 18-163 days). The mean age was 55±17 years, and there were 68 men (65%). Thirty-five patients (33%) had a history of rheumatic carditis and 43 (41%) had a prosthetic valve. There were 40 (38%) cases of staphylococcal IE, 32 (30%) of streptococcal IE and six (6%) of enterococcal IE. Cardiogenic shock, septic shock and clinically relevant cerebral complications were strongly associated with death from any cause (hazard ratio [HR] 16.85, 95% confidence interval [CI] 5.45-52.05 [P<0.001]; HR 2.62, 95% CI 1.23-5.56 [P=0.01]; and HR 4.14, 95% CI 1.92-8.92 [P<0.001], respectively). Seventy-three patients (69%) had a theoretical indication for surgery, which was performed in 38 patients (36%). Lack of surgery when there was a theoretical indication was significantly associated with death (HR 6.93, 95% CI 3.47-13.83; P<0.0001).

Conclusions: The pattern of IE in French Polynesia differs from Western countries in many ways. Postrheumatic valvular disease remains the main underlying disease, and access to emergency heart surgery is still a challenge.

Keywords: Cardiac surgery; Cardiopathie rhumatismale; Chirurgie cardiaque; Endocardite; Endocarditis; Epidemiology; Rheumatic heart disease; Valve disease; Valvulopathies; Épidémiologie.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Endocarditis / diagnosis
  • Endocarditis / epidemiology*
  • Endocarditis / mortality
  • Endocarditis / therapy*
  • Female
  • Health Services Accessibility
  • Heart Valve Prosthesis / adverse effects*
  • Heart Valve Prosthesis Implantation / adverse effects*
  • Heart Valve Prosthesis Implantation / instrumentation
  • Humans
  • Male
  • Middle Aged
  • Polynesia / epidemiology
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / epidemiology*
  • Prosthesis-Related Infections / mortality
  • Prosthesis-Related Infections / therapy*
  • Retrospective Studies
  • Rheumatic Heart Disease / diagnosis
  • Rheumatic Heart Disease / epidemiology*
  • Rheumatic Heart Disease / mortality
  • Rheumatic Heart Disease / therapy*
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents